GlobeNewswire 03.10.2025 Luke Bryan and Bayer discuss the Take Care, Now campaign With YourUpdateTV
GlobeNewswire 02.10.2025 AskBio Announces 6 Presentations at the European Society of Gene and Cell Therapy 32nd Annual Meetin...
GlobeNewswire 30.09.2025 Tonix Pharmaceuticals Further Strengthens Commercial Leadership Team with Appointment of Ganesh Kama...
GlobeNewswire 26.09.2025 Evkeeza® (evinacumab-dgnb) ANGPTL3 Antibody Approved in the U.S. for Children as Young as 1 Year Old...
GlobeNewswire 25.09.2025 BotCity Secures $12 Million Series A Funding to Address Growing Risks in “Shadow Automation”
GlobeNewswire 24.09.2025 Daré Bioscience to Receive up to $499,000 to Support Preeclampsia Research
GlobeNewswire 24.09.2025 BIO-Europe® 2025: Vienna Prepares to Welcome Global Biopharma Leaders
GlobeNewswire 22.09.2025 First European Participants Randomized in AskBio Phase 2 Gene Therapy Trial of AB-1005 for Parkinson...
GlobeNewswire 22.09.2025 First Parkinson’s disease patient treated in BlueRock’s pivotal Phase III trial of investigational c...
GlobeNewswire 22.09.2025 Press Release: Sanofi and Regeneron’s Dupixent to treat chronic spontaneous urticaria advances in EU...
GlobeNewswire 22.09.2025 Dupixent® (dupilumab) to Treat Chronic Spontaneous Urticaria (CSU) Advances in EU with Positive CHMP...
GlobeNewswire 19.09.2025 Alvotech Announces Marketing Approval in Japan of Three New Biosimilars
GlobeNewswire 19.09.2025 Regeneron Donates Ebola Treatment for Use in Countries Most at Risk of Outbreaks
GlobeNewswire 17.09.2025 Results from Phase 2 COURAGE Trial Demonstrating Potential to Improve Quality of GLP-1 receptor agon...
GlobeNewswire 17.09.2025 AskBio Announces Completion of Enrollment in Phase 1 Clinical Trial of AB-1005 Gene Therapy for Mult...
GlobeNewswire 17.09.2025 Regeneron Announces Positive Phase 3 Trial in Adults with Ultra-Rare Genetic Disorder Fibrodysplasia...
GlobeNewswire 16.09.2025 Expert with Bayer Discusses the U.S. Launch of Aspirina Families with YourUpdateTV
GlobeNewswire 16.09.2025 Parexel Announces Appointment of Rob Goodwin as Chief Operating Officer
GlobeNewswire 16.09.2025 Indicium Receives Investment from Databricks Ventures
TeleTrader 11.09.2025 Europe closes higher after ECB decision
GlobeNewswire 10.09.2025 Dewpoint Therapeutics Closes Series D Financing to Advance First-in-Class Condensate Modulator (c-mo...
GlobeNewswire 09.09.2025 Libtayo® (cemiplimab) Plus Chemotherapy Results at Five Years Reinforce Significant and Durable Impr...
GlobeNewswire 08.09.2025 DIH Appoints Barrett Mooney, Ph.D to DIH Holding US, Inc. Board of Directors 
GlobeNewswire 08.09.2025 Regeneron Advances Allergy Pipeline with Two Positive Phase 3 Trials Evaluating First-in-Class Antib...
GlobeNewswire 08.09.2025 CHARM Therapeutics Appoints Dr Erkut Bahceci as Chief Medical Officer